Department of Biomedical Engineering, Faculty of Science and Engineering, Toyo University, 2100 Kujirai, Kawagoe, Saitama 350-8585, Japan.
J Mater Chem B. 2020 Sep 14;8(34):7633-7641. doi: 10.1039/d0tb01520b. Epub 2020 Jul 28.
Understanding the interactions of eukaryotic cellular membranes with nanomaterials is required to construct efficient and safe nanomedicines and molecular bioengineering. Intracellular uptake of nanocarriers by active endocytosis limits the intracellular distribution to the endosomal compartment, impairing the intended biological actions of the cargo molecules. Nonendocytic intracellular migration is another route for nanomaterials with cationic or amphiphilic properties to evade the barrier function of the lipid bilayer plasma membranes. Direct transport of nanomaterials into cells is efficient, but this may cause cytotoxic or biocidal effects by temporarily disrupting the biological membrane barrier. We have recently discovered that nonendocytic internalization of synthetic amphipathic polymer-based nanoaggregates that mimic the structure of natural phospholipids can occur without inducing cytotoxicity. Analysis using a proton leakage assay indicated that the polymer enters cells by amphiphilicity-induced membrane fusion rather than by transmembrane pore formation. These noncytotoxic cell-penetrating polymers may find applications in drug delivery systems, gene transfection, cell therapies, and biomolecular engineering.
了解真核细胞膜与纳米材料的相互作用对于构建高效、安全的纳米药物和分子生物工程至关重要。纳米载体通过主动内吞作用被细胞内摄取,限制了其在内涵体隔室中的分布,从而损害了货物分子的预期生物学作用。对于带有正电荷或两亲性的纳米材料而言,非内吞性的细胞内迁移是另一种逃避脂质双层质膜屏障功能的途径。纳米材料的直接细胞转运效率很高,但这可能会通过暂时破坏生物膜屏障而导致细胞毒性或杀菌作用。我们最近发现,模拟天然磷脂结构的合成两亲性聚合物纳米聚集体的非内吞性内化可以在不诱导细胞毒性的情况下发生。使用质子渗漏测定法进行的分析表明,聚合物通过两亲性诱导的膜融合进入细胞,而不是通过跨膜孔形成进入细胞。这些非细胞毒性的穿胞聚合物可能在药物传递系统、基因转染、细胞治疗和生物分子工程中得到应用。